Clinical Study of Atorvastatin Calcium Combined With Metoprolol in the Treatment of CHF
Download as PDF
DOI: 10.38007/Proceedings.0001192
Author(s)
Mengqi Jia, Liguo Jian
Corresponding Author
Mengqi Jia
Abstract
Objective: Study on the clinical effect of metoprolol combined with atorvastatin on chronic heart failure (CHF). Methods: 106 patients with chronic heart failure from October 2017 to September 2018 were selected. According to the principle of random distribution, the patients were divided into control group (n = 53) and experimental group (n = 53). Both groups were treated with conventional methods, among which, the observation group will be treated with metoprolol and atorvastatin calcium at the same time. Finally, the results are obtained by comparing the therapeutic effects. Result: Indexes of cardiac function, the indexes of heart function, inflammatory factors and blood lipid in the experimental group were better than those in the control group (P < 0.05). Conclusion: metoprolol combined with atorvastatin calcium has a good clinical effect on chronic heart failure, which can effectively improve heart function. Therefore, metoprolol combined with atorvastatin calcium is worthy of clinical promotion.
Keywords
CHF; Atorvastatin Calcium Combined; Metoprolol; Clinical Study